A centralized recipient database enhances the serologic safety of RBC transfusions for patients with sickle cell disease

Sarah K. Harm, Mark H. Yazer, Grace Monis, Darrell J. Triulzi, James P. AuBuchon, Meghan Delaney

Research output: Contribution to journalArticle

31 Citations (Scopus)

Abstract

Objectives: To evaluate the utility of a centralized transfusion service model in preventing the transfusion of incompatible units in patients with sickle cell disease (SCD). Methods: The serologic records of transfused patients with SCD were reviewed. The index hospital was where an alloantibody was initially detected. Results: In total, 150 patients with SCD were evaluated; 66 (44.0%) of 150 were alloimmunized. In 42 (63.6%) of these patients, 1 or more antibodies evanesced. The median number of hospitals visited by patients with SCD for RBC transfusion with 1 or more evanesced antibodies was three (range, one to eight); the median number of nonindex hospitals was two (range, one to seven). Of the patients with evanesced antibodies, 28.6% received transfusions at various nonindex hospitals 20 or more times after the antibody evanesced. Conclusions: A centralized database can help identify patients with SCD who have evanesced alloantibodies and prevent issuing incompatible RBC units.

Original languageEnglish (US)
Pages (from-to)256-261
Number of pages6
JournalAmerican Journal of Clinical Pathology
Volume141
Issue number2
DOIs
StatePublished - Jan 1 2014
Externally publishedYes

Fingerprint

Sickle Cell Anemia
Databases
Safety
Isoantibodies
Antibodies

Keywords

  • Alloantibody
  • Centralized transfusion service
  • Database
  • Delayed hemolytic reaction
  • Evanescence
  • Red blood cell
  • Sickle cell

ASJC Scopus subject areas

  • Pathology and Forensic Medicine

Cite this

A centralized recipient database enhances the serologic safety of RBC transfusions for patients with sickle cell disease. / Harm, Sarah K.; Yazer, Mark H.; Monis, Grace; Triulzi, Darrell J.; AuBuchon, James P.; Delaney, Meghan.

In: American Journal of Clinical Pathology, Vol. 141, No. 2, 01.01.2014, p. 256-261.

Research output: Contribution to journalArticle

Harm, Sarah K. ; Yazer, Mark H. ; Monis, Grace ; Triulzi, Darrell J. ; AuBuchon, James P. ; Delaney, Meghan. / A centralized recipient database enhances the serologic safety of RBC transfusions for patients with sickle cell disease. In: American Journal of Clinical Pathology. 2014 ; Vol. 141, No. 2. pp. 256-261.
@article{0759bc143aa04b93b611a4fb5cfa0dd9,
title = "A centralized recipient database enhances the serologic safety of RBC transfusions for patients with sickle cell disease",
abstract = "Objectives: To evaluate the utility of a centralized transfusion service model in preventing the transfusion of incompatible units in patients with sickle cell disease (SCD). Methods: The serologic records of transfused patients with SCD were reviewed. The index hospital was where an alloantibody was initially detected. Results: In total, 150 patients with SCD were evaluated; 66 (44.0{\%}) of 150 were alloimmunized. In 42 (63.6{\%}) of these patients, 1 or more antibodies evanesced. The median number of hospitals visited by patients with SCD for RBC transfusion with 1 or more evanesced antibodies was three (range, one to eight); the median number of nonindex hospitals was two (range, one to seven). Of the patients with evanesced antibodies, 28.6{\%} received transfusions at various nonindex hospitals 20 or more times after the antibody evanesced. Conclusions: A centralized database can help identify patients with SCD who have evanesced alloantibodies and prevent issuing incompatible RBC units.",
keywords = "Alloantibody, Centralized transfusion service, Database, Delayed hemolytic reaction, Evanescence, Red blood cell, Sickle cell",
author = "Harm, {Sarah K.} and Yazer, {Mark H.} and Grace Monis and Triulzi, {Darrell J.} and AuBuchon, {James P.} and Meghan Delaney",
year = "2014",
month = "1",
day = "1",
doi = "10.1309/AJCP47QAAXTOZEKJ",
language = "English (US)",
volume = "141",
pages = "256--261",
journal = "American Journal of Clinical Pathology",
issn = "0002-9173",
publisher = "American Society of Clinical Pathologists",
number = "2",

}

TY - JOUR

T1 - A centralized recipient database enhances the serologic safety of RBC transfusions for patients with sickle cell disease

AU - Harm, Sarah K.

AU - Yazer, Mark H.

AU - Monis, Grace

AU - Triulzi, Darrell J.

AU - AuBuchon, James P.

AU - Delaney, Meghan

PY - 2014/1/1

Y1 - 2014/1/1

N2 - Objectives: To evaluate the utility of a centralized transfusion service model in preventing the transfusion of incompatible units in patients with sickle cell disease (SCD). Methods: The serologic records of transfused patients with SCD were reviewed. The index hospital was where an alloantibody was initially detected. Results: In total, 150 patients with SCD were evaluated; 66 (44.0%) of 150 were alloimmunized. In 42 (63.6%) of these patients, 1 or more antibodies evanesced. The median number of hospitals visited by patients with SCD for RBC transfusion with 1 or more evanesced antibodies was three (range, one to eight); the median number of nonindex hospitals was two (range, one to seven). Of the patients with evanesced antibodies, 28.6% received transfusions at various nonindex hospitals 20 or more times after the antibody evanesced. Conclusions: A centralized database can help identify patients with SCD who have evanesced alloantibodies and prevent issuing incompatible RBC units.

AB - Objectives: To evaluate the utility of a centralized transfusion service model in preventing the transfusion of incompatible units in patients with sickle cell disease (SCD). Methods: The serologic records of transfused patients with SCD were reviewed. The index hospital was where an alloantibody was initially detected. Results: In total, 150 patients with SCD were evaluated; 66 (44.0%) of 150 were alloimmunized. In 42 (63.6%) of these patients, 1 or more antibodies evanesced. The median number of hospitals visited by patients with SCD for RBC transfusion with 1 or more evanesced antibodies was three (range, one to eight); the median number of nonindex hospitals was two (range, one to seven). Of the patients with evanesced antibodies, 28.6% received transfusions at various nonindex hospitals 20 or more times after the antibody evanesced. Conclusions: A centralized database can help identify patients with SCD who have evanesced alloantibodies and prevent issuing incompatible RBC units.

KW - Alloantibody

KW - Centralized transfusion service

KW - Database

KW - Delayed hemolytic reaction

KW - Evanescence

KW - Red blood cell

KW - Sickle cell

UR - http://www.scopus.com/inward/record.url?scp=84895125818&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84895125818&partnerID=8YFLogxK

U2 - 10.1309/AJCP47QAAXTOZEKJ

DO - 10.1309/AJCP47QAAXTOZEKJ

M3 - Article

VL - 141

SP - 256

EP - 261

JO - American Journal of Clinical Pathology

JF - American Journal of Clinical Pathology

SN - 0002-9173

IS - 2

ER -